Hvad er oversættelsen af " CYTOTOKSISK KEMOTERAPI " på engelsk?

• cytotoxic chemotherapy

Eksempler på brug af Cytotoksisk kemoterapi på Dansk og deres oversættelser til Engelsk

Blev behandlet med cytotoksisk kemoterapi.
Being treated with cytotoxic chemotherapy.

Cytotoksisk kemoterapi lægemiddel der ødelægger hurtigt voksende celler.
Cytotoxic chemotherapy medicines that destroy rapidly growing cells.

Hovedparten af disse patienter var også udsat for cytotoksisk kemoterapi.
The majority of these subjects were also exposed to cytotoxic chemotherapy.

Cytotoksisk kemoterapi lægemiddel der à ̧delægger hurtigt voksende celler.
Cytotoxic chemotherapy medicines that destroy rapidly growing cells.

Disse tilfælde er forvekslet med både den tilgrundliggende sygdom samt cytotoksisk kemoterapi.
The reports are confounded by both the underlying disease state and the cytotoxic chemotherapy.

Filgrastim bør ikke anvendes til at øge dosis af cytotoksisk kemoterapi ud over de fastlagte behandlingsplaner se nedenfor.
Filgrastim should not be used to increase the dose of cytotoxic chemotherapy beyond established dosage regimens see below.

Der er ikke udført interaktionsundersøgelser af samtidig brug af febuxostat og cytotoksisk kemoterapi.
Drug interaction studies of febuxostat with cytotoxic chemotherapy have not been conducted.

Hos patienter i cytotoksisk kemoterapi ses typisk en forbigående stigning i neutrofiltallene 1- 2 dage efter påbegyndt behanding med filgrastim.
In patients receiving cytotoxic chemotherapy, a transient increase in neutrophil counts is typically seen 1- 2 days after initiation of filgrastim therapy.

Filgrastims sikkerhed og virkning er den samme hos voksne og børn, der får cytotoksisk kemoterapi.
The safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.

Etableret cytotoksisk kemoterapi Filgrastim kan gives som en daglig subkutan injektion eller som en daglig intravenøs infusion over 30 minutter.
Established cytotoxic chemotherapy Filgrastim may be administered as a daily subcutaneous injection or alternatively as a daily intravenous infusion over 30 minutes.

Den første dosis filgrastim må ikke administreres inden for de første 24 timer efter cytotoksisk kemoterapi.
The first dose of filgrastim should not be administered less than 24 hours following cytotoxic chemotherapy.

Den første dosis filgrastim bør tidligst administreres 24 timer efter cytotoksisk kemoterapi, men inden for 24 timer efter knoglemarvsinfusion.
The first dose of filgrastim should not be administered less than 24 hours following cytotoxic chemotherapy and within 24 hours of bone marrow infusion.

Dosisrekommandationerne til børn er de samme som til voksne, der får myelosuppressiv cytotoksisk kemoterapi.
The dosage recommendations in paediatric patients are the same as those in adults receiving myelosuppressive cytotoxic chemotherapy.

Brug af filgrastim til patienter i cytotoksisk kemoterapi medfører signifikant reduktion af incidens, sværhedsgrad og varighed af neutropeni og febril neutropeni.
Use of filgrastim in patients undergoing cytotoxic chemotherapy leads to significant reductions in the incidence, severity and duration of neutropenia and febrile neutropenia.

Behandling med Herceptin må kun påbegyndes af en læge med erfaring i administration af cytotoksisk kemoterapi se 4. 4.
Herceptin treatment should only be initiated by a physician experienced in the administration of cytotoxic chemotherapy see 4.4.

Brug af filgrastim hos patienter, som får cytotoksisk kemoterapi fører til signifikant reduceret forekomst, sværhedsgrad og varighed af neutropeni og febrile neutropenier.
Use of filgrastim in patients undergoing cytotoxic chemotherapy leads to significant reductions in the incidence, severity and duration of neutropenia and febrile neutropenia.

Doseringsanbefalingerne til pædiatriske patienter er de samme som til voksne i myelosuppressiv cytotoksisk kemoterapi.
The dosage recommendations in paediatric patients are the same as those in adults receiving myelosuppressive cytotoxic chemotherapy.

Ud over imatinib, havde 35% af patienterne tidligere modtaget cytotoksisk kemoterapi, 65% havde tidligere modtaget interferon, og 10% havde tidligere modtaget stamcelletransplantation.
In addition to imatinib, 35% of patients had received prior cytotoxic chemotherapy, 65% had received prior interferon, and 10% had received a prior stem cell transplant.

Neulasta blev undersøgt i to hovedundersøgelser med deltagelse af 467 patienter med brystkræft, der blev behandlet med cytotoksisk kemoterapi.
Neulasta has been studied in two main studies involving 467 patients with breast cancer who were being treated with cytotoxic chemotherapy.

Hos patienter med non- Hodgkin lymfom, der fik rituximab i kombination med cytotoksisk kemoterapi, er der i meget sjældne tilfælde rapporteret om reaktivering af hepatitis B se non- Hodgkin lymfom.
In patients with non-Hodgkin' s lymphoma receiving rituximab in combination with cytotoxic chemotherapy, very rare cases of hepatitis B reactivation have been reported see non-Hodgkin' s lymphoma.

Kepivance bør ikke indgives inden for 24 timer før, under infusion af, eller inden for 24 timer efter indgivelse af cytotoksisk kemoterapi.
Kepivance should not be administered within 24 hours before, during infusion of, or within 24 hours after administration of cytotoxic chemotherapy.

På grund af den potentielle sensivitet af hurtigt delende myeloide celler over for cytotoksisk kemoterapi, bør Neulasta administreres cirka 24 timer efter cytotoksisk kemoterapi.
Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ Neulasta should be administered approximately 24 hours after administration of cytotoxic chemotherapy.

I randomiserede, placebokontrollerede kliniske forsøg øgede filgrastim ikke forekomsten af bivirkninger forbundet med cytotoksisk kemoterapi.
In randomised, placebo-controlled clinical studies, filgrastim did not increase the incidence of undesirable effects associated with cytotoxic chemotherapy.

Reduktion i varigheden af neutropeni og forekomst af febril neutropeni hos patienter behandlet med cytotoksisk kemoterapi for malignitet med undtagelse af kronisk myeloid leukæmi og myelodysplastisk syndromer.
Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy with the exception of chronic myeloid leukaemia and myelodysplastic syndromes.

I randomiserede, placebokontrollerede kliniske forsøg medførte filgrastim ikke stigning i incidensen af de bivirkninger, der forbindes med cytotoksisk kemoterapi.
In randomised, placebo-controlled clinical trials, filgrastim did not increase the incidence of undesirable effects associated with cytotoxic chemotherapy.

Anvendelse af Myocet bør begrænses til afdelinger, der er specialiseret i indgivelse af cytotoksisk kemoterapi, og det bør kun indgives under overvågning af en læge, der har erfaring i anvendelse af kemoterapi..
The use of Myocet should be confined to units specialised in the administration of cytotoxic chemotherapy and should only be administered under the supervision of a physician experienced in the use of chemotherapy..

Er indiceret til behandling af patienter med lokal fremskreden eller metastatisk brystkræft efter svigt af cytotoksisk kemoterapi.
Xeloda in combination with docetaxel(see section 5.1) is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy.

Sikkerheden og virkningen af filgrastim givet samme dag som myelosuppresiv cytotoksisk kemoterapi er ikke dokumenteret.
The safety and efficacy of filgrastim given on the same day as myelosuppressive cytotoxic chemotherapy have not been definitively established.

Der er rapporteret om tilfælde af reaktivering af hepatitis B, hvoraf de fleste forekom hos patienter, som fik MabThera i kombination med cytotoksisk kemoterapi.
Cases of hepatitis B reactivation, have been reported, the majority of which were in subjects receiving MabThera in combination with cytotoxic chemotherapy.

Filgrastims sikkerhed og effekt, når det gives på samme dag som myelosuppressiv cytotoksisk kemoterapi, er ikke endeligt fastlagt.
The safety and efficacy of filgrastim given on the same day as myelosuppressive cytotoxic chemotherapy have not been definitively established.

Hvordan man bruger "cytotoksisk kemoterapi" i en Dansk sætning

Disse tilstande kan skyldes anvendelse af cytotoksisk kemoterapi (medicin, der nedbryder hurtigvoksende celler).

København: Politikens Forlag, s. 17-25 Bør alle yngre mammacancerpatienter tilbydes adjuverende cytotoksisk kemoterapi?

Standard cytotoksisk kemoterapi Den anbefalede dosis filgrastim er 0,5 mio.

Hvordan man bruger "cytotoxic chemotherapy" i en Engelsk sætning

Neoprene gloves offer outstanding permeation resistance to cytotoxic chemotherapy drugs.

Cytotoxic chemotherapy such as anthracyclines, etoposide, cyclophosphamide, vincristine, and prednisone.

The cytotoxic chemotherapy was well tolerated.

Cytotoxic chemotherapy is an effective treatment for invasive breast cancer.

Cytotoxic chemotherapy other than lymphodepletion within 14 days of CAR-T cell infusion.

Conclusion: BMECs protect AML cells from conventional cytotoxic chemotherapy partly through adhesion factors.

Cytotoxic chemotherapy represents a major component of anti-cancer treatment strategies.

Since 2004, docetaxel has become the preferred cytotoxic chemotherapy option for symptomatic mCRPC.

It is probably impossible to cure NMC with cytotoxic chemotherapy alone.

Thus, cytotoxic chemotherapy represents the mainstay of treatment for early and metastatic TNBC.